Australians will soon have more options when it comes to daily contact lenses following the launch of Johnson and Johnson’s Acuvue Oasys Max 1-Day

United States researchers have found melatonin use is associated with a decreased risk of development and progression of age-related macular degeneration (AMD).

Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and

Key issues faced by the deafblind community will be highlighted on 18 June when a group of deafblind Australians, community, service and research organisations